Cartalax
Also known as: Ala-Glu-Asp-Arg, Cartilage bioregulator, Khavinson cartilage peptide
- Half-life:
- Unknown
Administration Routes
Mechanism of Action
Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells
A Khavinson peptide bioregulator targeting cartilage tissue. Promotes chondrocyte activity and cartilage matrix regeneration; studied for osteoarthritis and joint degeneration.
Primary Research Areas
- cartilage regeneration
- joint repair
- chondrocyte function support
Risk Profile
Generally considered lower risk in research contexts. Consult a healthcare professional before use.
Regulatory Status
Russian joint/cartilage peptide bioregulator (Khavinson Institute). Not FDA-approved. Not on any FDA list. Research chemical in US.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Where to Find Cartalax
No active associated providers listed yet.